5.81 USD
↗ 0.02 (0.35%)AT CLOSE (03:59 PM EST)
Emergent Biosolutions, Inc. (EBS) trades at $5.94 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest EBS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.